|
613 Call to boost
pharmacy public health role in Scotland Community Pharmacy Scotland has called on the Scottish Government to increase community pharmacists’ role in public health
PJ 2008;280:613
Full Text
613 Pharmacy input on drug misuse overlooked
by Welsh Assembly The Welsh Assembly was
criticised this week for ignoring the role that community pharmacists
can play in helping to deliver its 10-year strategy to reduce drug misuse
and for failing to consult the profession during development of the proposals
PJ 2008;280:613
Full Text
613 New alcohol campaign kicks off in England An online tool that calculates the number of units in an alcoholic drink has been launched by the Government as part of a £6m publicity campaign to encourage people to keep their drinking habits within healthy limits
PJ 2008;280:613
Full Text
614 Promote pharmacists’ expertise
more, ABPI urges Publicity led by the Royal Pharmaceutical
Society to educate the public about the medicines expertise of pharmacists is
one of the recommendations put forward in a new report produced by the Association
of the British Pharmaceutical Industry and the Long-term Conditions Alliance
PJ 2008;280:614
Full Text
614 Raltegravir endorsed for NHS use in Scotland Raltegravir
(Isentress) has been accepted for use within NHS Scotland in combination with
other antiretroviral agents for the treatment of HIV-1 infection in treatment-experienced
adults
PJ 2008;280:614
Full Text
614 New treatment for chronic myelogenous leukaemia Nilotinib — a new protein-kinase inhibitor — is now available for treating chronic myelogenous leukaemia (CML). Marketed by Novartis as Tasigna, the medicine is indicated for the treatment of adults with chronic phase and accelerated phase Philadelphia chromosome positive CML, with resistance or intolerance to previous therapy, including imatinib
PJ 2008;280:614
Full Text
614Scotland’s Deputy First Minister opens Glasgow pharmacy Scotland’s Deputy First Minister and Cabinet Secretary for Health and Wellbeing Nicola Sturgeon officially opened High Street Pharmacy in Glasgow this month
PJ 2008;280:614
Full Text
615 Virgin Healthcare in talks
with pharmacy businesses Virgin Healthcare, the division of Richard Branson’s business empire that is looking to move into general practice, is in talks with several pharmacy companies, The Journal can reveal
PJ 2008;280:615
Full Text
615 PSNC backs doctor dispensing in remote areas “We have no wish for a dispute with dispensing doctors,” Pharmaceutical Services Negotiating Committee chief executive Sue Sharpe said this week following a House of Commons debate on the future of GP dispensing
PJ 2008;280:615
Full Text
615 Digital orders for repeat scripts About
8 million UK patients will soon be able to order repeat prescriptions digitally
PJ 2008;280:615
Full Text
615 Clarification on PCT procurement The approaches and behaviours that service providers should expect of primary care trust commissioners are clarified in a new Department of Health guide, “PCT procurement guide for health services”
PJ 2008;280:615
Full Text
615 Williams retires from PSNC Steven
Williams has retired from the Pharmaceutical Services Negotiating Committee after
six years as chairman of the funding and contract subcommittee and as a member
of the negotiating team
PJ 2008;280:615
Full Text
616 Strategies to minimise
dispensing errors identified Several strategies
for minimising dispensing incidents have been suggested by researchers after
a study showed that dispensing the wrong strength of the correct drug is the
most common error reported by Welsh hospitals
PJ 2008;280:616
Full Text
616 Double checking medicines may contribute
to rather than stop errors Double checking medicines
to ensure accuracy may actually contribute to errors rather than prevent them,
a researcher suggests
PJ 2008;280:616
Full Text
616 Pharmacists in Canada oppose EHC move from
behind the counter Emergency hormonal contraception
(EHC) is being made available on pharmacy shelves rather than from behind the
counter in Canada following a recommendation from the regulatory authorities
PJ 2008;280:616
Full Text
617 Pre-pandemic bird flu
vaccine approved for Europe This week the first marketing authorisation for an H5N1 pre-pandemic vaccine for humans — GlaxoSmithKline’s Prepandrix — has been granted by the European Commission
PJ 2008;280:617
Full Text
617 Pharmacist independent prescribing may improve
antibiotic use Prudent use of antibiotics will
increase as more pharmacists qualify as independent prescribers, a group of MPs,
healthcare professionals and patient group and industry representatives were
told this week
PJ 2008;280:617
Full Text
617 Chronic diseases overtaking infectious diseases,
says WHO Chronic conditions, such as heart disease
and stroke, are overtaking infectious diseases like tuberculosis and malaria
as the main causes of death across the world, according to new statistics published
by the World Health Organization this week
PJ 2008;280:617
Full Text
617 New alliance to improve access to affordable
drugs in developing countries The Medicines Transparency
Alliance, which aims to contribute to increased access to affordable essential
medicines in developing countries in co-operation with pharmaceutical companies,
was launched last week
PJ 2008;280:617
Full Text
618 Treatment with haemostatic
agent does not improve stroke survival Therapy
with the haemostatic agent recombinant activated factor VII (rFVIIa) reduces
haematoma growth but does not improve survival or reduce severe disability after
intracerebral haemorrhage, findings of a phase III trial show
PJ 2008;280:618
Full Text
618 SSRI may help head/neck cancer depression Prophylactic
treatment with citalopram may decrease the incidence of depression in patients
undergoing therapy for head and neck cancer, a double-blind pilot trial suggests
PJ 2008;280:618
Full Text
618 Three-monthly regimen for psoriasis Ustekinumab, a human interleukin-12/23 monoclonal antibody, administered by subcutaneous injection every 12 weeks, led to at least a 75 per cent improvement in the psoriasis area and severity index score in 66–76 per cent of patients compared with 3–4 per cent of placebo-treated patients
PJ 2008;280:618
Full Text
618 Hope for pulmonary fibrosis Pirfenidone, an anti-inflammatory and antifibrotic compound, stabilises lung function and improves progression-free survival in patients with idiopathic pulmonary fibrosis, according to a phase III study presented at the American Thoracic Society’s international conference in Toronto this week
PJ 2008;280:618
Full Text
618 New development programme AstraZeneca’s AZD0424, a tyrosine kinase inhibitor, is the first drug to enter Cancer Research UK’s clinical development partnerships programme
PJ 2008;280:618
Full Text
618 Guanfacine reduces ADHD symptoms Guanfacine,
a selective alpha2A-adrenoceptor agonist, has been shown to reduce symptoms of
attention deficit hyperactivity disorder (ADHD) in clinical trials
PJ 2008;280:618
Full Text
619 Benefits of antihypertensives
independent of age The benefits of reducing blood pressure with various antihypertensive drugs are independent of patients’ ages, according to research published
PJ 2008;280:619
Full Text
619 Outcomes not improved when PCI is facilitated
with abciximab Using abciximab plus reteplase or abciximab alone to facilitate percutaneous coronary intervention (PCI) does not improve clinical outcomes in patients with ST-segment elevation myocardial infarction, an international, multicentre study published this week shows. Furthermore, incidence of major haemorrhage was found to be increased
PJ 2008;280:619
Full Text
620 No clearly superior drug
therapy for osteoporosis Differences in non-vertebral
fracture risk between adults prescribed risedronate or raloxifene and those prescribed
alendronate are small, a new analysis reveals. However, patients with osteoporosis
receiving nasal calcitonin may be at a higher risk for non-vertebral fractures
than alendronate recipients
PJ 2008;280:620
Full Text
620 Online medicines management training wins
IT award for Northumbrian hospital trust An online
medicines management training programme for hospital staff, developed by pharmacists,
has won national recognition
PJ 2008;280:620
Full Text
620 Long-term funding for IM&T support announced
in Scotland New funding for primary care information management and technology (IM&T) facilitators was announced this week by the Scottish Government. The facilitators support pharmacists, doctors and dentists with the IM&T aspects of their respective contracts in Scotland
PJ 2008;280:620
Full Text
620 Scottish palliative care Palliative care model schemes will continue in Scotland, following a 2008–09 funding announcement for NHS boards made this week by the Scottish Government
PJ 2008;280:620
Full Text
620 Prescribing training for medics The
British National Formulary is at the centre of a new online learning tool for
medical students
PJ 2008;280:620
Full Text
620 Survey highlights role in obesity Over
90 per cent of pharmacists think they are best placed to advise patients how
their behaviour can help them lose weight, a survey of 350 European pharmacists
reveals
PJ 2008;280:620
Full Text |
The
Pharmaceutical Journal